SULTOPRIDE

Sultopride is a benzamide antipsychotic acting as a selective D2 antagonist. Used for schizophrenia and psychomotor agitation. Side effects include QT prolongation, sedation, hypotension, and extrapyramidal symptoms.

SKU: 655afe5d4e16 Category: Tag:

Product Description


Mechanism of Action

SULTOPRIDE (ID 27540) exhibits an expansive biochemical activity architecture integrating multi‑directional signalling modulation, catalytic‑pathway interference, mitochondrial‑network recalibration, ion‑flux reorganisation, cytoskeletal remodelling, membrane‑dynamics alteration and transcription‑factor axis redistribution. Its molecular topology allows docking to catalytic residues, allosteric gates, hydrophobic receptor cavities, charged transmembrane helices and polymeric protein scaffolds, giving the compound broad influence across metabolic, genomic, electrophysiological and structural systems.

At the signalling level, SULTOPRIDE may perturb phosphorylation gradients, alter ERK/JNK/MAPK propagation velocities, reorganise PI3K–AKT survival‑pathway bias, shift G‑protein coupling efficiency, regulate Ca²⁺ microdomains, reshape IP₃/DAG secondary‑messenger maps and influence cAMP‑PKA amplitude dynamics. Mitochondrially, it may modify membrane‑potential polarity, adjust ETC complex activation ratios, reshape ATP/ADP turnover behaviour and alter ROS leakage thresholds.

High‑Precision Research Applications

  • Deep kinome interference mapping and signalling‑cascade simulations
  • High‑resolution docking, ligand‑stability prediction & conformational flow analysis
  • Mitochondrial stress modelling & organelle cross‑talk dynamics
  • UPR/ER‑stress and integrated autophagy–mitophagy pathway analysis
  • Multi‑omics regulatory‑network reconstruction (transcriptome, phosphoproteome, metabolome)
  • Actin/tubulin turnover modelling and cytoskeletal force‑distribution mapping
  • Cell‑fate mapping across apoptosis, necroptosis, ferroptosis and parthanatos
  • Machine‑learning SAR/QSAR pipelines for advanced molecular optimisation

Toxicodynamics & Cellular Hazard Spectrum

  • ROS surge and collapse of antioxidant‑buffer systems
  • Mitochondrial fragmentation or ETC‑chain suppression
  • Severe ionic‑flux destabilisation including Ca²⁺ overload
  • Cytoskeletal disassembly & membrane‑integrity breakdown
  • Hyperactivation of NF‑κB, STAT and IRF inflammatory axes
  • Induction of programmed‑cell‑death pathways
  • Epigenetic drift affecting methylation, acetylation and chromatin compaction

For expert laboratory use only — not intended for biological exposure.

Datasheet


Molecular Formula

C15H24N2O4S2

Molecular Weight

354.5 g/mol

CAS Number

53583-79-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Insoluble

Purity

Purity information is available upon request (COA).

Synonym

Sultopride; 53583-79-2; Sultopridum; Sultoprida; AA0G3TW31W

IUPAC/Chemical Name

N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide

InChl Key

UNRHXEPDKXPRTM-UHFFFAOYSA-N

InChl Code

InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)

References

https://pubchem.ncbi.nlm.nih.gov/compound/5357;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download